Cardiac Troponin T and NT-proBNP for Prediction of 30-Day Readmission or Death in Patients with Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study
Cardiology · 2023
DOI: 10.1159/000533266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, 2023. Verfasst von Rahul Bhatnagar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway, rahul.bhatnagar@studmed.uio.no. Hauptthemen laut MEDLINE: Troponin T, Natriuretic Peptide, Brain, Patient Readmission, Dyspnea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponin T (cTnT) measurements are recommended in patients with acute dyspnea. We aimed to assess the prognostic merit of cTnT compared to NT-proBNP for 30-day readmission or death in patients hospitalized with acute dyspnea.
Methods
We measured cTnT and NT-proBNP within 24 h in 314 patients hospitalized with acute dyspnea and adjudicated the cause of the index admission. Time to first event of readmission or death ≤30 days after hospital discharge was recorded, and cTnT and NT-proBNP measurements were compared head-to-head.
Results
Patients who died (12/314) or were readmitted (71/314) within 30 days had higher cTnT concentrations (median: 32.6, Q1–Q3: 18.4–74.2 ng/L vs. median: 19.4, Q1–Q3: 8.4–36.1 ng/L; p for comparison <0.001) and NT-proBNP concentrations (median: 1,753.6, Q1–Q3: 464.2–6,862.0 ng/L vs. median 984, Q1–Q3 201–3,600 ng/L; for comparison p = 0.027) compared to patients who survived and were not readmitted. cTnT concentrations were associated with readmission or death within 30 days after discharge both in the total cohort (adjusted hazard ratio [aHR]: 1.64, 95% confidence interval [CI]: 1.30–2.05) and in patients with heart failure (HF) (aHR: 1.58, 95% CI: 1.14–2.18). In contrast, NT-proBNP concentrations were not associated with short-term events, neither in the total cohort (aHR: 1.10, 95% CI: 0.94–1.30) nor in patients with adjudicated HF (aHR: 1.06, 95% CI: 0.80–1.40). Conclusion: cTnT concentrations are associated with 30-day readmission or death in patients hospitalized with acute dyspnea, as well as in patients adjudicated HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway, rahul.bhatnagar@studmed.uio.no.
- K.G. Jebsen Center for Cardiac Biomarkers, University of Oslo, Oslo, Norway, rahul.bhatnagar@studmed.uio.no.
- Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.
- K.G. Jebsen Center for Cardiac Biomarkers, University of Oslo, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Division for Diagnostics and Technology, Akershus University Hospital, Lørenskog, Norway.
Zitieren
APA
Bhatnagar, R., Berge, K., Røysland, R., Høiseth, A. D., Brynildsen, J., Christensen, G., Omland, T., Røsjø, H., & Lyngbakken, M. N. (2023). Cardiac Troponin T and NT-proBNP for Prediction of 30-Day Readmission or Death in Patients with Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study. Cardiology. https://doi.org/10.1159/000533266
Vancouver
Bhatnagar R, Berge K, Røysland R, Høiseth AD, Brynildsen J, Christensen G, et al. Cardiac Troponin T and NT-proBNP for Prediction of 30-Day Readmission or Death in Patients with Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study. Cardiology. 2023. doi:10.1159/000533266
BibTeX
@article{Bhatnagar2023,
author = {Bhatnagar, Rahul and Berge, Kristian and Røysland, Ragnhild and Høiseth, Arne Didrik and Brynildsen, Jon and Christensen, Geir and Omland, Torbjørn and Røsjø, Helge and Lyngbakken, Magnus Nakrem},
title = {Cardiac Troponin T and NT-proBNP for Prediction of 30-Day Readmission or Death in Patients with Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study},
journal = {Cardiology},
year = {2023},
doi = {10.1159/000533266}
}
EUVIMED